HULDREBERG BIOKONSULT AS

Operating

Salg av diverse biologiske produkter.

Lage og selge biologiske undervisningsopplegg til skoler og universitet i Norge. Eksempelvis har vi utviklet pedagogiske undervisningsopplegg innen temaet hjerte, lunger og nyrer. Det arbeides med å utarbeide tilsvarende undervisningsopplegg for andre sentrale områder i biologiopplæringen. Den biologiske kompetansen brukes også til å bistå hytteeierne med å anlegge grøntanlegg/torvtak m.m. på sine hytteeiendommer.

Organization

CEO: AB
Arvid Berg1944
Chairman of the board: AB
Arvid Berg1944
Years since formation: 8 years; since Feb 8, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 30; 1 share class
Total number of shareholders: 2; persons

Financials

Total operating income 2025: 205,091; NOK
Annual total result 2025: 1,856; NOK

Last update: Jul 28, 2026

Management

Management / administration

Name	Role	Shares
AB Arvid Berg 1944	Managing Director/CEO	53.33 % directly

Board

Name	Role	Shares
AB Arvid Berg 1944	Chairman	53.33 % directly
RT Rita Thorsrud Berg 1983	Board Member	-

Others

Name	Role	Shares
S SPAREBANK 1 REGNSKAPSHUSET VALHALL AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
AB Arvid Berg 1944	Managing Director/CEO, Chairman	53.33 % directly
TN Tommy Nitschke 1984	-	46.67 % directly

Last update: Feb 6, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
AB Arvid Berg 1944	Ordinary shares	16	53.33 %
TN Tommy Nitschke 1984	Ordinary shares	14	46.67 %

Shares owned by the HULDREBERG BIOKONSULT AS

Name	Share class	Total number of shares	Share
B BLUE BAY CLUB AS	NO0010367808	395,000	4.46 %
N NORSKE SKOG ASA	NO0010861115	750	< 0.01 %
P PETRONOR E&P ASA	NO0012942525	64	< 0.01 %
E EQUINOR ASA	NO0010096985	35	< 0.01 %
S SCATEC ASA	NO0010715139	128	< 0.01 %
P PANORO ENERGY ASA	NO0010564701	250	< 0.01 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	205,091	190,887	162,242	168,192	152,709
Annual Total Result	1,856	14,880	33,516	109,885	35,265
Total assets	0	257,827	264,214	242,121	114,137
Total liabilities	0	27,806	49,073	60,497	42,398
Total equity	0	230,021	215,140	181,624	71,739

P&L

Year	2025	2024	2023	2022	2021
Total operating income	205,091	190,887	162,242	168,192	152,709
Total operating costs	205,179	174,345	117,585	96,332	108,537
Operating result	-88	16,542	44,657	71,860	44,172
Financial income/costs	1,960	1,989	1,180	69,059	-273
Profit before tax	1,873	18,530	45,837	140,919	43,899
Total tax & extraordinary income/cost	17	3,650	12,321	31,034	8,634
Annual Total Result	1,856	14,880	33,516	109,885	35,265

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	50,000	50,000	86,552	50,000
Total current assets	207,827	214,214	155,569	64,137
Total assets	257,827	264,214	242,121	114,137
Short term debt	27,806	49,073	60,497	42,398
Long term debt	0	0	0	0
Total liabilities	27,806	49,073	60,497	42,398
Contributed capital	24,430	24,430	24,430	24,430
Retained earnings	205,591	190,710	157,194	47,309
Total equity	230,021	215,140	181,624	71,739
Total equity and liabilities	257,827	264,214	242,121	114,137

Classification

21st company classification

BETA

Scaleup

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

HULDREBERG BIOKONSULT AS920 396 887